Max Healthcare Institute Limited has informed the Exchange about execution of Sale Deed for acquisition of Land and building situated in Uttar Pradesh by Crosslay Remedies Limited
MAXHEALTH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than Nifty 100 and 2.4 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Max Healthcare's wholly-owned subsidiary Crosslay Remedies Limited (CRL) has executed a Sale Deed to acquire a 4,000 sq. meter land parcel along with an existing building adjacent to its Max Super Speciality Hospital in Vaishali, Ghaziabad. The deal is valued at approximately ₹120 crore (excluding stamp duty and registration), with an additional ₹200 crore to be invested for constructing new beds. This acquisition will enable the addition of around 140 beds to the existing 387-bed hospital, which has been running at over 80% capacity utilization throughout FY25. The expansion is expected to be completed within 30 months and will be funded through CRL's internal cash and accruals.
This is a positive capacity-expansion move for Max Healthcare, aimed at addressing high demand in the Ghaziabad/UP region. The total investment of ~₹320 crore is self-funded with no debt or equity dilution, and should support future revenue and bed-capacity growth once operational. No open offer is triggered as this is an asset purchase by an existing wholly-owned subsidiary.